Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-089604
Filing Date
2025-06-24
Accepted
2025-06-24 18:05:05
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9939
  Complete submission text file 0000950170-25-089604.txt   11388
Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Issuer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATEA PHARMACEUTICALS, INC. 125 SUMMER STREET BOSTON MA 02110
Business Address
Lucidi Bruno (Reporting) CIK: 0001829622 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39661 | Film No.: 251070386